IndraLab

Statements

P5091 activates apoptosis myeloma. 1 / 1

| 1

eidos

"P5091 can induce the apoptosis of multiple myeloma ( MM ) cells resistant to traditional therapy or bortezomib by inhibiting the activity of USP7 , and can also play a synergistic role when used in combination with dexamethasone or lenalidomide ."

33925279

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 activates apoptosis myeloma. 1 / 1

INDRA sources:

Databases

Reading